Leukapheresis Guidelines and Tisagenlecleucel Manufacturing in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia
Lamis Eldjerou
American Society of Gene & Cell Therapy Annual Meeting 2020